Robin Vacha - Jan 31, 2023 Form 4 Insider Report for Azenta, Inc. (AZTA)

Role
SVP, GM Life Science Products
Signature
/s/ Jason W. Joseph, Attorney-in-fact for Robin Vacha
Stock symbol
AZTA
Transactions as of
Jan 31, 2023
Transactions value $
$12,434
Form type
4
Date filed
2/2/2023, 03:08 PM
Previous filing
Nov 21, 2022
Next filing
Aug 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZTA Common Stock Award $12.4K +265 +0.82% $46.92 32.5K Jan 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act